Total Payments
$1,011
2023 Payments
$255.84
Companies
10
Transactions
46
Medicare Patients
889
Medicare Billing
$99,993
Payment Breakdown by Category
Food & Beverage$888.40 (87.8%)
Education$122.98 (12.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $888.40 | 43 | 87.8% |
| Education | $122.98 | 3 | 12.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $332.22 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $256.42 | 15 | $0 (2023) |
| Janssen Products, LP | $93.99 | 2 | $0 (2019) |
| ViiV Healthcare Company | $77.03 | 4 | $0 (2017) |
| Astellas Pharma US Inc | $59.71 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $57.91 | 4 | $0 (2017) |
| Allergan Inc. | $53.73 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $45.55 | 3 | $0 (2017) |
| AbbVie, Inc. | $18.03 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $16.79 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $255.84 | 3 | Gilead Sciences, Inc. ($179.04) |
| 2022 | $16.79 | 1 | Janssen Pharmaceuticals, Inc ($16.79) |
| 2019 | $107.04 | 3 | Gilead Sciences, Inc. ($49.06) |
| 2017 | $631.71 | 39 | Janssen Biotech, Inc. ($179.62) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/18/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $76.80 | General |
| Category: Oncology | ||||||
| 02/16/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $54.04 | General |
| Category: HCV | ||||||
| 07/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/30/2019 | Janssen Products, LP | Symtuza (Drug) | Education | In-kind items and services | $28.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/06/2019 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $49.06 | General |
| Category: HIV | ||||||
| 01/18/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $28.99 | General |
| 12/21/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Virology | ||||||
| 12/20/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/29/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $15.52 | General |
| 10/03/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2017 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: HIV | ||||||
| 09/21/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 09/14/2017 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: HIV | ||||||
| 09/13/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/20/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/19/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/22/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/14/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/09/2017 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: HIV | ||||||
| 06/08/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $10.97 | General |
| 06/06/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/31/2017 | E.R. Squibb & Sons, L.L.C. | SUSTIVA (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Virology | ||||||
| 05/30/2017 | Astellas Pharma US Inc | Cresemba (Drug), Mycamine, Ambisome | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Infectious Diseases | ||||||
| 05/18/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 193 | 294 | $76,059 | $20,240 |
| 2022 | 5 | 177 | 299 | $72,450 | $19,378 |
| 2021 | 6 | 281 | 509 | $113,762 | $33,766 |
| 2020 | 6 | 238 | 430 | $86,160 | $26,610 |
Total Patients
889
Total Services
1,532
Medicare Billing
$99,993
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 134 | $28,051 | $8,110 | 28.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 61 | $23,947 | $5,862 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 61 | $11,608 | $2,703 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 26 | $7,915 | $2,404 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,539 | $1,162 | 25.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 163 | $31,640 | $8,880 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 50 | $20,122 | $5,109 | 25.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 30 | $8,276 | $2,294 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 45 | $8,177 | $2,106 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $4,236 | $989.21 | 23.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 104 | 294 | $57,197 | $16,367 | 28.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 85 | 89 | $29,079 | $9,348 | 32.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 41 | 64 | $10,083 | $2,947 | 29.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 30 | $8,324 | $2,401 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 20 | $4,899 | $1,462 | 29.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $4,181 | $1,241 | 29.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 86 | 242 | $47,841 | $13,598 | 28.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 59 | 63 | $16,240 | $6,856 | 42.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 47 | 74 | $10,117 | $2,508 | 24.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 20 | 22 | $6,251 | $1,817 | 29.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 13 | 13 | $4,537 | $1,223 | 27.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 13 | 16 | $1,175 | $608.22 | 51.8% |
About Jenae Limoges
Jenae Limoges is a Specialist healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679552244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenae Limoges has received a total of $1,011 in payments from pharmaceutical and medical device companies, with $255.84 received in 2023. These payments were reported across 46 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($888.40).
As a Medicare-enrolled provider, Limoges has provided services to 889 Medicare beneficiaries, totaling 1,532 services with total Medicare billing of $99,993. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Lewiston, ME
- Active Since 01/12/2006
- Last Updated 05/25/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1679552244
Products in Payments
- PREZCOBIX (Drug) $244.62
- TRIUMEQ (Drug) $77.03
- ERLEADA (Drug) $76.80
- SUSTIVA (Drug) $57.91
- Epclusa (Drug) $54.04
- Biktarvy (Drug) $49.06
- ISENTRESS (Drug) $45.55
- DALVANCE (Drug) $35.29
- Symtuza (Drug) $28.99
- TEFLARO (Drug) $18.44
- Mavyret (Drug) $18.03
- XARELTO (Drug) $16.79
- Cresemba (Drug) $16.72
- Mycamine (Drug) $14.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lewiston
Dr. Donna Feldman, Md, MD
Specialist — Payments: $2,255
Specialist $2,255
Richard Lambert, M.d, M.D
Specialist — Payments: $1,557
Specialist $1,557
Carl Dettwiler, Md, MD
Specialist — Payments: $779.59
Specialist $779.59
Liliana Saunero-Nava, M.d, M.D
Specialist — Payments: $310.04
Specialist $310.04
Daniel Miller, Md, MD
Specialist — Payments: $153.70
Specialist $153.70
Mrs. Sarina Bax-Debiaso, M.d, M.D
Specialist — Payments: $112.65
Specialist $112.65